These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 18582868
1. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135). Zhu J, Kuei C, Sutton S, Kamme F, Yu J, Bonaventure P, Atack J, Lovenberg TW, Liu C. Eur J Pharmacol; 2008 Aug 20; 590(1-3):43-52. PubMed ID: 18582868 [Abstract] [Full Text] [Related]
2. Relaxin-3, INSL5, and their receptors. Liu C, Lovenberg TW. Results Probl Cell Differ; 2008 Aug 20; 46():213-37. PubMed ID: 18236022 [Abstract] [Full Text] [Related]
3. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7. Liu C, Kuei C, Sutton S, Shelton J, Zhu J, Nepomuceno D, Hossain MA, Wade JD, Bathgate RA, Bonaventure P, Lovenberg T. Ann N Y Acad Sci; 2009 Apr 20; 1160():31-7. PubMed ID: 19416155 [Abstract] [Full Text] [Related]
4. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4. Hu MJ, Shao XX, Wang JH, Wei D, Guo YQ, Liu YL, Xu ZG, Guo ZY. Sci Rep; 2016 Jul 11; 6():29648. PubMed ID: 27404393 [Abstract] [Full Text] [Related]
5. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions. Wang XY, Guo YQ, Shao XX, Liu YL, Xu ZG, Guo ZY. Arch Biochem Biophys; 2014 Sep 15; 558():127-32. PubMed ID: 25043977 [Abstract] [Full Text] [Related]
6. Development of a selective agonist for relaxin family peptide receptor 3. Wei D, Hu MJ, Shao XX, Wang JH, Nie WH, Liu YL, Xu ZG, Guo ZY. Sci Rep; 2017 Jun 12; 7(1):3230. PubMed ID: 28607363 [Abstract] [Full Text] [Related]
7. Membrane receptors: structure and function of the relaxin family peptide receptors. Kong RC, Shilling PJ, Lobb DK, Gooley PR, Bathgate RA. Mol Cell Endocrinol; 2010 May 14; 320(1-2):1-15. PubMed ID: 20138959 [Abstract] [Full Text] [Related]
8. Receptors for relaxin family peptides. Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ. Ann N Y Acad Sci; 2005 May 14; 1041():61-76. PubMed ID: 15956688 [Abstract] [Full Text] [Related]
9. Structure and activity in the relaxin family of peptides. Tregear GW, Bathgate RA, Hossain MA, Lin F, Zhang S, Shabanpoor F, Scott DJ, Ma S, Gundlach AL, Samuel CS, Wade JD. Ann N Y Acad Sci; 2009 Apr 14; 1160():5-10. PubMed ID: 19416150 [Abstract] [Full Text] [Related]
10. Structural properties of relaxin chimeras. Haugaard-Jönsson LM, Hossain MA, Daly NL, Bathgate RA, Wade JD, Craik DJ, Rosengren KJ. Ann N Y Acad Sci; 2009 Apr 14; 1160():27-30. PubMed ID: 19416154 [Abstract] [Full Text] [Related]
11. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays. Wu H, Hoare BL, Handley TNG, Akhter Hossain M, Bathgate RAD. Biochem Pharmacol; 2024 Jun 14; 224():116238. PubMed ID: 38677442 [Abstract] [Full Text] [Related]
12. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135. Sutton SW, Bonaventure P, Kuei C, Nepomuceno D, Wu J, Zhu J, Lovenberg TW, Liu C. Neuroendocrinology; 2005 Jun 14; 82(3-4):139-50. PubMed ID: 16679775 [Abstract] [Full Text] [Related]
13. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation. Wang XY, Guo YQ, Zhang WJ, Shao XX, Liu YL, Xu ZG, Guo ZY. FEBS J; 2014 Jul 14; 281(13):2927-36. PubMed ID: 24802387 [Abstract] [Full Text] [Related]
14. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways. Halls ML, van der Westhuizen ET, Bathgate RA, Summers RJ. Br J Pharmacol; 2007 Mar 14; 150(6):677-91. PubMed ID: 17293890 [Abstract] [Full Text] [Related]
15. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays. Zhang WJ, Jiang Q, Wang XY, Song G, Shao XX, Guo ZY. J Pept Sci; 2013 Jun 14; 19(6):350-4. PubMed ID: 23526726 [Abstract] [Full Text] [Related]
16. Addition of a carboxy-terminal green fluorescent protein does not alter the binding and signaling properties of relaxin family Peptide receptor 3. van der Westhuizen ET, Wade JD, Sexton PM, Summers RJ. Ann N Y Acad Sci; 2009 Apr 14; 1160():105-7. PubMed ID: 19416168 [Abstract] [Full Text] [Related]
17. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization. Kuei C, Sutton S, Bonaventure P, Pudiak C, Shelton J, Zhu J, Nepomuceno D, Wu J, Chen J, Kamme F, Seierstad M, Hack MD, Bathgate RA, Hossain MA, Wade JD, Atack J, Lovenberg TW, Liu C. J Biol Chem; 2007 Aug 31; 282(35):25425-35. PubMed ID: 17606621 [Abstract] [Full Text] [Related]
18. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4. Ang SY, Hutchinson DS, Evans BA, Hossain MA, Patil N, Bathgate RA, Kocan M, Summers RJ. Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan 31; 390(1):105-111. PubMed ID: 27888281 [Abstract] [Full Text] [Related]
19. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3). van der Westhuizen ET, Christopoulos A, Sexton PM, Wade JD, Summers RJ. Mol Pharmacol; 2010 May 31; 77(5):759-72. PubMed ID: 20159943 [Abstract] [Full Text] [Related]
20. Recent progress in relaxin-3-related research. Liu C, Bonaventure P, Sutton SW, Chen J, Kuei C, Nepomuceno D, Lovenberg TW. Ann N Y Acad Sci; 2005 May 31; 1041():47-60. PubMed ID: 15956687 [Abstract] [Full Text] [Related] Page: [Next] [New Search]